Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence

A significant proportion of patients with primary biliary cirrhosis (PBC) suffer from severe fatigue. The aim of this study was to characterize patterns of daytime sleep in patients with PBC (using both objective and subjective assessment approaches) and to study the association between sleep abnormality and fatigue severity. Fatigue severity was assessed in 48 female subjects with PBC (using a disease‐specific quality of life instrument (the PBC‐40) and a generic fatigue measure (Fatigue Impact Scale [FIS]) as well as 48 case‐matched normal controls. All participants also completed the Pittsburgh Sleep Quality Index (PSQI) and the Epworth Sleepiness Scale (ESS, which assesses daytime hypersomnolence). Objective sleep assessment was performed using accelerometry over 7 days. Global sleep quality assessed by the PSQI was significantly lower in the PBC group compared to controls (P < .0001). ESS scores were significantly higher in patients with PBC than controls (P = .0001), suggesting significantly greater daytime somnolence in the patients with PBC. Objective sleep assessment confirmed that subjects with PBC were sleeping on average almost twice as long as controls during the daytime. Both degree of daytime somnolence (ESS) and actual daytime sleep activity (accelerometry) correlated strongly with fatigue severity in the patient group (r2 = 0.5, P < .0001 and r2 = 0.2, P < .01, respectively). In conclusion, Sleep abnormality, in the form of excessive daytime somnolence, is present in a significant proportion of patients with PBC, with the degree of daytime somnolence correlating strongly with the degree of fatigue. Existing agents effective at reducing daytime somnolence (such as modafinil) hold potential for the treatment of fatigue in PBC. (HEPATOLOGY 2006;44:91–98.)

[1]  J. Newton,et al.  Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure. , 2006, Journal of hepatology.

[2]  P. Kubes,et al.  TNF‐α–secreting monocytes are recruited into the brain of cholestatic mice , 2006 .

[3]  M. Kaplan,et al.  Modafinil for the treatment of fatigue in primary biliary cirrhosis. , 2005, Annals of internal medicine.

[4]  A. Jacoby,et al.  Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis , 2005, Gut.

[5]  Y. Chrétien,et al.  Quality of life in patients with primary biliary cirrhosis , 2004, Hepatology.

[6]  A. Cross,et al.  The relationship of sleep disturbances and fatigue in multiple sclerosis. , 2004, Archives of neurology.

[7]  J. Hajnal,et al.  Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels , 2004, Gut.

[8]  E. Levy,et al.  Effects of bile acids on biliary epithelial cells: proliferation, cytotoxicity, and cytokine secretion. , 2003, Life sciences.

[9]  David E. J. Jones,et al.  The true impact of fatigue in primary biliary cirrhosis: a population study. , 2002, Gastroenterology.

[10]  D. Jones,et al.  Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. , 2000, Journal of hepatology.

[11]  A. Tran,et al.  Impact of fatigue on the quality of life of patients with primary biliary cirrhosis , 2000, American Journal of Gastroenterology.

[12]  Kazuhide Yamamoto,et al.  Cytokine Profile in the Liver of Primary Biliary Cirrhosis , 1999, Journal of Clinical Immunology.

[13]  K. Rioux,et al.  Augmented interleukin‐1β–induced depression of locomotor activity in cholestatic rats , 1998, Hepatology.

[14]  D. Stewart,et al.  Fatigue in primary biliary cirrhosis , 1998, Gut.

[15]  M. Swain,et al.  Chronic cholestasis in rats induces anhedonia and a loss of social interest , 1998, Hepatology.

[16]  D. Papanicolaou,et al.  Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. , 1997, The Journal of clinical endocrinology and metabolism.

[17]  D. Kripke,et al.  The role of actigraphy in the evaluation of sleep disorders. , 1995, Sleep.

[18]  M. Gershwin,et al.  Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis , 1995, Hepatology.

[19]  M. Johns,et al.  Sleepiness in different situations measured by the Epworth Sleepiness Scale. , 1994, Sleep.

[20]  G. Chrousos,et al.  Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. , 1993, The Journal of clinical endocrinology and metabolism.

[21]  Y. Gyoten.  Current ethical problems in Japan , 1993, Gastroenterologia Japonica.

[22]  T. Ishikawa,et al.  Interleukin 6 production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection and primary biliary cirrhosis , 1993, Gastroenterologia Japonica.

[23]  Daniel J Buysse,et al.  The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research , 1989, Psychiatry Research.

[24]  D. Jones,et al.  Primary biliary cirrhosis. , 1960, Journal of internal medicine.

[25]  P. Kubes,et al.  TNF-alpha-secreting monocytes are recruited into the brain of cholestatic mice. , 2006, Hepatology.

[26]  K. Rammohan,et al.  A variant in the HS1-BP3 gene is associated with familial essential tremor , 2005, Neurology.

[27]  K. Lindor,et al.  Primary biliary cirrhosis , 1998, Springer Netherlands.